Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy

BACKGROUND. Treatment of splenic marginal zone lymphoma (SMZL) patients is not standardized. Recent data suggest that rituximab is highly effective and could be considered as initial therapy. AIM. To assess the efficacy of rituximab monotherapy in a large series of patients with SMZL and compare the...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Kalpadakis, Christina, Pangalis, Gerassimos A., Angelopoulou, Maria K., Sachanas, Sotirios, Kontopidou, Flora N., Yiakoumis, Xanthi, Kokoris, Stella I., Dimitriadou, Evagelia M., Dimopoulou, Maria N., Moschogiannis, Maria, Korkolopoulou, Penelope, Kyrtsonis, Marie-Christine, Siakantaris, Marina P., Papadaki, Theodora, Tsaftaridis, Panayiotis, Plata, Eleni, Papadaki, Helen E., Vassilakopoulos, Theodoros P.
التنسيق: Artigo
اللغة:Inglês
منشور في: AlphaMed Press 2013
الموضوعات:
Lymphoma
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579603/
https://ncbi.nlm.nih.gov/pubmed/23345547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0251
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة